The prevalence of sympathetic overactivity in primary hypertensive patients. - SORT

Study identifier:NIS-CIN-DUM-2010/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A non interventional, cross sectional, study on the prevalence of sympathetic overactivity in hypertensive patients.

Medical condition

essential hypertension

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1514

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Feb 2011
Primary Completion Date: 01 Feb 2012
Study Completion Date: 01 Feb 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria